CIK 0001728328 · <br>Emerging growth company
InMed Pharmaceuticals Inc.
Sign in to watch- Tickers
- INM MTRI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (604) 669-7207
- Business address
- C/O NORTON ROSE FULBRIGHT CANADA LLP, SUITE 1800 - 510 WEST GEORGIA STREET, VANCOUVER, British Columbia, Canada, V6B 0M3
Securities
- INM Common stock Nasdaq
- MTRI Common Stock Nasdaq
- Open-market buys, last 90 days
- $238,371
- in 7 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$238,371. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-19 | Jagpal Netta Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +18,000 | 24,250 | ||
| 2025-12-19 | WOUDENBERG MICHAEL Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +18,000 | 25,445 | ||
| 2025-12-19 | Bathery John Steven Director | Grant or award · Employee Stock Option (Right to Buy) | +1,750 | 5,250 | ||
| 2025-12-19 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Grant or award · Employee Stock Option (Right to Buy) | +13,000 | 18,280 | ||
| 2025-12-19 | ADAMS ERIC A President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +35,000 | 49,050 | ||
| 2025-12-19 | HULL ANDREW Director | Grant or award · Employee Stock Option (Right to Buy) | +1,750 | 2,711 | ||
| 2025-12-15 | HULL ANDREW Director | Other disposition · Employee Stock Option (Expiration) | −14 | 961 | ||
| 2025-12-15 | ADAMS ERIC A President & CEO | Other disposition · Employee Stock Option (Expiration) | −250 | 14,050 | ||
| 2025-12-15 | WOUDENBERG MICHAEL Chief Operating Officer | Other disposition · Employee Stock Option (Expiration) | −60 | 7,445 | ||
| 2025-12-15 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Other disposition · Employee Stock Option (Expiration) | −70 | 5,280 | ||
| 2025-10-17 | Klompas Neil A Director | Grant or award · Employee Stock Option (Right to Buy) | +3,500 | 3,500 | ||
| 2025-01-11 | HULL ANDREW Director | Other disposition · Employee Stock Option (Expiration) | −2 | 975 | ||
| 2024-12-20 | Johnson Shane Aaron Sr VP & General Manager | Grant or award · Employee Stock Option (Right to Buy) | +1,500 | 3,900 | ||
| 2024-12-20 | Jagpal Netta Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +3,750 | 6,250 | ||
| 2024-12-20 | Lemerond Nicole Director | Grant or award · Employee Stock Option (Right to Buy) | +550 | 975 | ||
| 2024-12-20 | WOUDENBERG MICHAEL Chief Operating Officer | Grant or award · Employee Stock Option (Right to Buy) | +3,750 | 7,505 | ||
| 2024-12-20 | Grove Janet P Director | Grant or award · Employee Stock Option (Right to Buy) | +550 | 975 | ||
| 2024-12-20 | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | Grant or award · Employee Stock Option (Right to Buy) | +2,750 | 5,350 | ||
| 2024-12-20 | ADAMS ERIC A President & CEO | Grant or award · Employee Stock Option (Right to Buy) | +6,250 | 14,300 | ||
| 2024-12-20 | Baldasare Bryan T Director | Grant or award · Employee Stock Option (Right to Buy) | +550 | 975 |
Page 4 of 8 · 149 trades